companies / paulexbio-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-07 json
| total_raised | 18,516,04018.5M | D |
|---|---|---|
| founded | null | |
| hq | LA JOLLA, CA | |
| industry | unknown | |
| stage | null |
Pharmaceuticals company based in LA JOLLA, CA
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-12-18 | Funding round | 18,516,04018.5M | null | D |
| person | role | src |
|---|---|---|
| Edgardo Rayo | director | D |
| Francisco Leon | director | D |
| Mohammad Hayat | director | D |
| Sanjuan Miguel | director | D |
| Sanjuan Miguel | executive | D |
Nginx 1.30.0, Express, Bootstrap 5.3.3, Typekit, Adobe Fonts, Google Analytics, Google Tag Manager, jQuery CDN, jsDelivr, DoubleClick Floodlight, WordPress, Node.js
| fact | status | src |
|---|---|---|
| Funding round, $18.5M | sourced | D |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-25latest_round: seed, $18.5M, 2025-12-18 → Funding round, $18.5M, 2025-12-18, D 2026-09-25 | latest_round | seed, $18.5M, 2025-12-18 → Funding round, $18.5M, 2025-12-18 | D 2026-09-25 |
| 2026-09-25provenance_round: attributed → sourced, D 2026-09-25 | provenance_round | attributed → sourced | D 2026-09-25 |
Records begin 2026-09-24. all_changes